Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer [PDF]
, 2004 Background Advanced ovarian cancer is the leading non-breast gynaecologic cause of malignant pleural effusion. Aim of this study was to assess the efficacy of mitoxantrone sclerotherapy as a palliative treatment of malignant pleural effusions due to ...
FH Hausheer +26 more
core +2 more sources
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update [PDF]
, 2010 Refractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. Large volume paracentesis and pleurodesis are regarded as first-line treatments in patients who do not respond ...
Gerbes, Alexander L., Roessle, Martin
core +1 more source
A Case of Acute Respiratory Distress Syndrome Following Pleurodesis With Talc
Clinical Medicine Insights: Case Reports, 2023 Management of malignant pleural effusion is a medical challenge, and several methods have been proposed to deal with it including thoracentesis, indwelling pleural catheter placement, and chemical or mechanical pleurodesis.
Ali Hossein Samadi Takaldani +3 more
doaj +1 more source
Blood‑patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: A case report [PDF]
, 2014 Pneumothorax in patients with progressive systemic sclerosis (PSS) often presents as a difficult‑to‑treat disease. Autologous blood‑patch pleurodesis has previously been used for the treatment of pneumothorax.
Hizawa Nobuyuki +11 more
core +1 more source
Journal of Pediatric Surgery Case Reports, 2018 Congenital chylothorax is a rare presentation of nonimmune hydrops fetalis (NIHF). We report a case of congenital chylothorax presenting as NIHF managed successfully with chemical pleurodesis.
Vilmaris Quinones Cardona, MD +3 more
doaj +1 more source
Journal of Chest Surgery, 2023 Background: Malignant pleural effusion affects many patients with advanced cancer. When chemotherapy or radiotherapy fails to relieve malignant pleural effusion and related symptoms, drainage and pleurodesis can help. Although surgical talc pleurodesis
Changsung Han +3 more
doaj +1 more source
Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study [PDF]
, 2012 BACKGROUND: None of the current pleurodesing agents fulfil all the criteria for best pleural sclerosant. Therefore, the search for the ideal agent for chemical pleurodesis still continues.
Elnaz Ansari +6 more
core +1 more source
Determination of In Vivo efficacy and safety of zeolite as a new pleurodesis agent
Toxicology Reports, 2022 Pleural effusion, the pathological condition in which an abnormal amount of pleural fluid is accumulated in the small space between the visceral and parietal pleurae of the lungs, can be treated by pleurodesis, whereby the pleural space is obliterated ...
Engin Sumer +5 more
doaj +1 more source
Chemical pleurodesis by small bore catheter in hepatic hydrothorax: A feasibility study
Egyptian Journal of Chest Disease and Tuberculosis, 2016 Background: Hepatic hydrothorax treatment remains problematic, and chemical pleurodesis can be considered. Objectives: The aim of this study is to compare the efficacy and safety of chemical pleurodesis by small bore catheter to tube drainage in hepatic ...
Asem A. Hewidy +2 more
doaj +1 more source
Talc pleurodesis for malignant pleural effusion: efficacy and factors predicting recurrence [PDF]
, 2014 Objectives: To identify potential factors predicting recurrence after talc pleurodesis for malignant pleural effusion. Methods: Retrospective study of two cohorts of consecutive patients undergoing surgery for malignant pleural effusion (T VATS/talc ...
Froeschle, P +3 more
core +1 more source